Arno Deger is a notable inventor based in Seeshaupt, Germany. He has made significant contributions to the field of immunoassays, holding a total of 6 patents. His work focuses on developing innovative methods for detecting substances through advanced biochemical techniques.

Latest Patents

One of Arno Deger's latest patents is a method for carrying out a homogeneous immunoassay based on agglutination. This invention utilizes a Fab′-biotin material and agglutinatable particles that carry streptavidin or avidin. The technology also involves a Fab′-biotin linked to a label compound capable of electrochemiluminescence, with the particles being magnetic. Another significant patent is a nucleic acid hybridization-based assay for determining a substance. This application describes homogeneous assays for identifying ligands by contacting a sample with a labeled substance and a receptor that binds specifically to the ligand of interest.

Career Highlights

Arno Deger is currently employed at Boehringer Mannheim GmbH, where he continues to advance his research in immunoassay technologies. His innovative approaches have positioned him as a key figure in the development of new diagnostic methods.

Collaborations

Throughout his career, Arno has collaborated with notable colleagues, including Michael Berger and Roland Schenk. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Arno Deger is a distinguished inventor whose work in immunoassay technology has led to significant advancements in the field. His contributions continue to impact the way substances are detected and analyzed in various applications.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com